Japanese scientists develop enhanced vitamin K for neuron regeneration

Researchers in Japan have created new vitamin K compounds that are three times more effective than natural forms at turning stem cells into neurons. The work, published in 2025, targets diseases that destroy brain cells such as Alzheimer’s and Parkinson’s.

Associate Professor Yoshihisa Hirota and Professor Yoshitomo Suhara led the team at Shibaura Institute of Technology. They combined vitamin K with elements of vitamin A to produce 12 hybrid molecules. One compound, called Novel VK, stood out in tests on mouse neural progenitor cells for its strong ability to promote neuronal growth.

Awọn iroyin ti o ni ibatan

Microscopic view of enhanced natural killer cells attacking cancer cells due to a drug developed by McGill researchers.
Àwòrán tí AI ṣe

McGill researchers use reversible drug approach to boost natural killer cells against hard-to-treat cancers

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

Researchers at McGill University report a drug-based method to temporarily enhance natural killer (NK) cells—an immune cell type—by inhibiting two proteins, improving the cells’ ability to attack several aggressive cancers in preclinical experiments.

Researchers at the University of Cambridge have developed miniature lab-grown models of the human brain and spinal cord that show damaged nerve fibers can regain the ability to regrow under certain conditions.

Ti AI ṣe iroyin

Researchers in Japan have identified an association between higher blood levels of vitamin C and greater gray matter volume plus stronger connectivity in a key brain network among adults over age 64.

Japanese researchers have identified a new seed of the amyloid beta protein. The discovery could lead to early-stage therapy for the neurodegenerative disease.

Ti AI ṣe iroyin

Researchers in Sweden have created insulin-producing cells from human stem cells that reversed diabetes symptoms when transplanted into mice. The cells matured after placement in the eye and maintained glucose regulation for months. The work was published in Stem Cell Reports.

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ